Gary Ingenito, Chief Medical & Reg. Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 293,848 shares at $6.60 ($1.9M) on 2022-06-21, disclosed to the SEC on 2022-06-23.
Open-market sale of $1.9M CPRX by Chief Medical & Reg. Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.60 | 143,848 | $949K | 49.0% |
| 2 | $6.60 | 143,848 | $949K | 49.0% |
| 3 | $6.61 | 6,152 | $41K | 2.1% |
| Total | $6.60 avg | 293,848 | $1.9M | 100% |
| Filing → |
| CPRX | SELL | 2024-11-29 | $545K | — | Filing → |
| CPRX | SELL | 2024-11-22 | $806K | — | Filing → |
| CPRX | SELL | 2024-08-13 | $1.8M | — | Filing → |